358
Views
48
CrossRef citations to date
0
Altmetric
Original Articles Clinical

Positron emission tomography in mantle cell lymphoma

, , , , , , , & show all
Pages 1693-1701 | Received 16 Feb 2008, Accepted 19 May 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Daniel M. Guidot, Jeffrey M. Switchenko, Loretta J. Nastoupil, Jean L. Koff, Kristie A. Blum, Joseph Maly, Christopher R. Flowers & Jonathon B. Cohen. (2018) Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility. Leukemia & Lymphoma 59:4, pages 888-895.
Read now
Rajesh Shrestha, Vijaya Raj Bhatt, Guru Subramanian Guru Murthy & James O. Armitage. (2015) Clinicopathologic features and management of blastoid variant of mantle cell lymphoma. Leukemia & Lymphoma 56:10, pages 2759-2767.
Read now
Meirav Kedmi, Irit Avivi, Elena Ribakovsky, Noam Benyamini, Tima Davidson, Elinor Goshen, Tamar Tadmor, Arnon Nagler & Abraham Avigdor. (2014) Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-d-glucose–positron emission tomography/computed tomography in mantle cell lymphoma?. Leukemia & Lymphoma 55:11, pages 2484-2489.
Read now
Eric D. Hsi & Peter Martin. (2014) Indolent mantle cell lymphoma. Leukemia & Lymphoma 55:4, pages 761-767.
Read now
Peter Martin & Bijal Shah. (2013) Limited-stage mantle cell lymphoma: not so different from advanced-stage. Leukemia & Lymphoma 54:2, pages 217-218.
Read now
Brian K. Link. (2008) The mysteries of mantle cell lymphoma–do PET scans provide a clue?. Leukemia & Lymphoma 49:9, pages 1662-1663.
Read now
Saar Gill, Rodney J. Hicks & John F. Seymour. (2008) What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?. Leukemia & Lymphoma 49:9, pages 1653-1656.
Read now

Articles from other publishers (41)

Toby A. Eyre, Mark J. Bishton, Rory McCulloch, Maeve O'Reilly, Robin Sanderson, Geetha Menon, Sunil Iyengar, David Lewis, Jonathan Lambert, Kim M. Linton & Pamela McKay. (2023) Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology.
Crossref
Ritanshu Solanki, AnwinJoseph Kavanal, Harmandeep Singh, Rajender Kumar & Gaurav Prakash. (2022) A rare case of massive bilateral renomegaly due to primary involvement by mantle cell lymphoma on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography . Indian Journal of Nuclear Medicine 37:3, pages 299.
Crossref
Tetiana Skrypets, Cristina Ferrari, Luca Nassi, Gloria Margiotta Casaluci, Benedetta Puccini, Lara Mannelli, Kateryna Filonenko, Irina Kryachok, Felice Clemente, Maria Carmela Vegliante, Antonella Daniele, Gianmauro Sacchetti, Attilio Guarini & Carla Minoia. (2021) 18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis. Journal of Personalized Medicine 11:2, pages 123.
Crossref
Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2020) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 153, pages 103038.
Crossref
Domenico Albano, Giorgio Treglia, Maria Gazzilli, Elisabetta Cerudelli, Raffaele Giubbini & Francesco Bertagna. (2020) 18F-FDG PET or PET/CT in Mantle Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 422-430.
Crossref
Shaoxi Yang, Lilan Fu, Meilinur AbuduRxiti, Jianhua Wu, Qiaoyu Wang, Yongde Qin, Xiaoguang Zou & Hongsheng Li. (2020) Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma. Nuclear Medicine Communications 41:5, pages 477-484.
Crossref
Young‐Woo Jeon, Joo‐Hyun O, Kyung‐Sin Park, Gi June Min, Sung‐Soo Park, Jae‐Ho Yoon, Ki‐Seong Eom, Chang‐Ki Min & Seok‐Goo Cho. (2019) Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP. British Journal of Haematology 188:6, pages 860-871.
Crossref
Domenico Albano, Riccardo Laudicella, Paola Ferro, Michela Allocca, Elisabetta Abenavoli, Ambra Buschiazzo, Alessia Castellino, Agostino Chiaravalloti, Annarosa Cuccaro, Lea Cuppari, Rexhep Durmo, Laura Evangelista, Viviana Frantellizzi, Sofya Kovalchuk, Flavia Linguanti, Giulia Santo, Matteo Bauckneht & Salvatore Annunziata. (2019) The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study. Cancers 11:12, pages 1831.
Crossref
Domenico Albano, Paola Ferro, Giovanni Bosio, Federico Fallanca, Alessandro Re, Alessandra Tucci, Andrés José Maria Ferreri, Piera Angelillo, Luigi Gianolli, Raffaele Giubbini & Francesco Bertagna. (2019) Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience. Clinical Lymphoma Myeloma and Leukemia 19:8, pages e457-e464.
Crossref
Domenico Albano, Giovanni Bosio, Nicola Bianchetti, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini & Francesco Bertagna. (2019) Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma. Annals of Nuclear Medicine 33:7, pages 449-458.
Crossref
Clément Bailly, Thomas Carlier, Cyrille Touzeau, Nicolas Arlicot, Françoise Kraeber-Bodéré, Steven Le Gouill & Caroline Bodet-Milin. (2019) Interest of FDG-PET in the Management of Mantle Cell Lymphoma. Frontiers in Medicine 6.
Crossref
C. Bodet-Milin, E. Itti & P.Y. Salaün. (2019) Lymphomes. Médecine Nucléaire 43:1, pages 150-160.
Crossref
Adalgisa Condoluci, Davide Rossi, Emanuele Zucca & Franco Cavalli. (2018) Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma. Current Oncology Reports 20:10.
Crossref
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson & Simon Rule. (2018) A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma. British Journal of Haematology 182:1, pages 63-70.
Crossref
Shawn Karls, Hina Shah & Heather Jacene. (2018) PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Seminars in Nuclear Medicine 48:1, pages 37-49.
Crossref
Stephen E. Spurgeon, Brian G. Till, Peter Martin, Andre H. Goy, Martin P. Dreyling, Ajay K. Gopal, Michael LeBlanc, John P. Leonard, Jonathan W. Friedberg, Lawrence Baizer, Richard F. Little, Brad S. Kahl & Mitchell R. Smith. (2016) Recommendations for Clinical Trial Development in Mantle Cell Lymphoma. Journal of the National Cancer Institute 109:1, pages djw263.
Crossref
S. Htet, S. Lane, D. Kipp, H. Rose & P. Campbell. (2016) PET-CT confirmed complete remission and MRD negativity in mantle cell lymphoma patients treated with R-hyper-CVAD results in excellent outcome in the absence of autologous stem cell transplantation: a single-centre case for a transplant-free approach. Internal Medicine Journal 46:9, pages 1113-1114.
Crossref
Anirban Mukherjee, Krishan Kant Agarwal, Ajay Gogia, Chandrasekhar Bal & Rakesh Kumar. (2016) Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT. Clinical Nuclear Medicine 41:4, pages e206-e207.
Crossref
Akshay D. Baheti, Sree Harsha Tirumani, Rani Sewatkar, Saboo S. Sachin, Atul B. Shinagare & Nikhil H. Ramaiya. (2015) MDCT of extranodal mantle cell lymphoma: a single institute experience. Abdominal Imaging 40:6, pages 1693-1699.
Crossref
Babak Rajabi & John W. Sweetenham. (2014) Mantle cell lymphoma: observation to transplantation. Therapeutic Advances in Hematology 6:1, pages 37-48.
Crossref
S Robinson, P Dreger, D Caballero, P Corradini, C Geisler, M Ghielmini, S Le Gouill, E Kimby, S Rule, U Vitolo, M Dreyling & O Hermine. (2014) The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. Leukemia 29:2, pages 464-473.
Crossref
Simone Ferrero & Martin Dreyling. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 143 168 .
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Michael E. Williams, L. Kyle Brett, Martin Dreyling, German Ott & Eric D. Hsi. 2014. Rare Lymphomas. Rare Lymphomas 277 302 .
J B Cohen, N C Hall, A S Ruppert, J A Jones, P Porcu, R Baiocchi, B A Christian, S Penza, D M Benson, J Flynn, L A Andritsos, S M Devine & K A Blum. (2013) Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma. Bone Marrow Transplantation 48:9, pages 1212-1217.
Crossref
Christian Schmidt & Martin H. Dreyling. 2013. Lymphoma. Lymphoma 157 175 .
P. McKay, M. Leach, R. Jackson, G. Cook & S. Rule. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology 159:4, pages 405-426.
Crossref
Lale Kostakoglu. 2012. A Case-Based Approach to PET/CT in Oncology. A Case-Based Approach to PET/CT in Oncology 329 365 .
Anthony R. Mato, Jakub Svoboda, Tatyana Feldman, Tania Zielonka, Harry Agress, David Panush, Mitchell Miller, Patrick Toth, Paul M. Lizotte, Sunita Nasta, Stuart Goldberg, Emeline Chong, Steven Schuster, Andrew L. Pecora & Andre Goy. (2011) Post‐treatment (not interim) positron emission tomography‐computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R‐HyperCVAD. Cancer 118:14, pages 3565-3570.
Crossref
Bijal D. Shah, Peter MartinEduardo M. Sotomayor. (2012) Mantle Cell Lymphoma: A Clinically Heterogeneous Disease in Need of Tailored Approaches. Cancer Control 19:3, pages 227-235.
Crossref
Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2012) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 82:1, pages 78-101.
Crossref
Ken Herrmann, Andreas K. Buck, Tibor Schuster, Martina Rudelius, Hans-Jürgen Wester, Nicolas Graf, Christine Scheuerer, Christian Peschel, Markus Schwaiger, Tobias Dechow & Ulrich Keller. (2011) A Pilot Study to Evaluate 3′-Deoxy-3′- 18 F-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma . Journal of Nuclear Medicine 52:12, pages 1898-1902.
Crossref
Peter J. Hosein, Vitor H. Pastorini, Fabio M. Paes, Daryl Eber, Jennifer R. Chapman, Aldo N. Serafini, Ash A. Alizadeh & Izidore S. Lossos. (2011) Utility of positron emission tomography scans in mantle cell lymphoma. American Journal of Hematology 86:10, pages 841-845.
Crossref
Stéphanie Harel, Richard Delarue, Vincent Ribrag, Martin Dreyling & Olivier Hermine. (2011) Treatment of Younger Patients With Mantle Cell Lymphoma. Seminars in Hematology 48:3, pages 194-207.
Crossref
Steven Le Gouill, Mohamad Mohty, Thierry Guillaume, Thomas Gastinne & Philippe Moreau. (2011) Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma: Where Are We Now and Which Way Should We Go?. Seminars in Hematology 48:3, pages 227-239.
Crossref
Abass Alavi, Sankaran Shrikanthan, Aysel Aydin, Roland Talanow & Stephen Schuster. (2011) Fluorodeoxyglucose-Positron-Emission Tomography Findings in Mantle Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 11:3, pages 261-266.
Crossref
Dominique Delbeke. 2011. Diseases of the Heart and Chest, Including Breast 2011–2014. Diseases of the Heart and Chest, Including Breast 2011–2014 193 198 .
Craig Hacking & Yuranga Weerakkody. 2005. Radiopaedia.org. Radiopaedia.org.
Caroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, Mehmet Sahin, Anne Moreau, Hervé Maisonneuve, Nadine Morineau, Henry Jardel, Philippe Moreau, Céline Gallazini-Crépin, Pascal Gries, Rémy Gressin, Jean-Luc Harousseau, Mohamad Mohty, Philippe Moreau, Françoise Kraeber-Bodere & Steven Le Gouill. (2010) Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group. European Journal of Nuclear Medicine and Molecular Imaging 37:9, pages 1633-1642.
Crossref
Stephen D. Smith, Eric Hsi, Brian Bolwell, Brad Pohlman, Robert Dean, Meagan Effinger, Amanda Maggiotto & John Sweetenham. (2010) Validation of the mantle cell lymphoma international prognostic index: A single‐center retrospective analysis. American Journal of Hematology 85:6, pages 454-456.
Crossref
Michele Ghielmini & Emanuele Zucca. (2009) How I treat mantle cell lymphoma. Blood 114:8, pages 1469-1476.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.